Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26)

Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26)

<p>Abstract</p> <p>Background</p> <p>The presence of an oligodendroglial component within a glioblastoma multiforme (GBM) is considered a prognostically favorable factor, but the clinical outcome of patients with glioblastoma multiforme with oligodendroglial component (...

Full description

Bibliographic Details
Main Authors: Warmuth-Metz Monika, Vince Giles H, Roggendorf Wolfgang, Rieckmann Peter, Ruprecht Klemens, Vordermark Dirk, Kölbl Oliver, Flentje Michael
Format: Article
Language:English
Published: BMC 2006-10-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/6/247

Internet

http://www.biomedcentral.com/1471-2407/6/247

Similar Items